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Folkloric or galenic preparations of valerian roots and rhizomes have been used as sedatives/anxiolytics and sleep
inducers since ancient times. “Valerianas” are plants that naturally grow in our region. Although some of them are
used in folk medicine, they lack scientific information. We performed a comparative study of the phytochemical
composition and the potential in vivo effects of ethanolic extracts of argentine valerian species: Valeriana carnosa
Sm., V. clarionifolia Phil. and V. macrorhiza Poepp. ex DC., from “Patagonia Argentina”; V. ferax (Griseb.) H€ock and
V. effusa Griseb., from the central part of our country, and V. officinalis (as the reference plant). All these plants
were rich in phenolic compounds, evidenced the presence of ligands for the benzodiazepine binding site of the
GABAA receptor and were able to induce sedation as assessed by loss-of-righting reflex assays (500 mg/kg, i.p.).
Mice treated with V. macrorhiza, V. carnosa and V. ferax extracts showed reduced exploratory behaviors while
V. clarionifolia produced anxiolytic-like activities (500 mg/kg, i.p.) in the Hole board test. Oral administrations
(300 mg/kg and 600 mg/kg, p.o.) evidenced sedative effects for V. ferax and anxiolytic-like properties for
V. macrorhiza, V. carnosa and V. clarionifolia extracts. Our native valerian species are active on the CNS, validating
its folkloric use as anxiolytic/sedative and sleep enhancers.1. Introduction
The roots and rhizomes of several valerian species and other related
plants (e.g. Nardus) have been the source of a peculiar fragrance
mentioned in the new Testament, and of a useful natural sedative known
many centuries before and recorded by Galen, Dioscorides and Pliny the
Elder. The therapeutic properties of Valerian, however, were already
mentioned in the Ayurvedic and Chinese Medicines (800 B. C. to 1000 A.
D.) (Dweck, 1997; Houghton, 1988).
In modern times the highly respectedmedicinal properties of Valerian
are attested by its citation in more than 20 Pharmacopoeias (Houghton,
1997) and extensive use in Europe, Asia and several other regions of the
world.arder).
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vier Ltd. This is an open access arValeriana (formerly Valerianaceae) is the largest genus of the Capri-
foliaceae family and contains about 200 species (The Plant List, 2013).
Even though V. officinalis L. is the “universally” considered species, there
are several other Valeriana sp. used for the same purposes, depending on
the region or country in question. For example, V. wallichii DC (Indian
Valerian), V. fauriei Briquet (Japanese Valerian) (Welfare, 1996) and
V. edulisNutt ex. Torr.&Gray (Morazzoni and Bombardelli, 1995) known
as “Valeriana mexicana”.
Several species of valerians naturally grow in our region. Some of
these species have been mentioned in our Argentine National Pharma-
copoeia as a substitute for Valeriana officinalis for more than 50 years,
based on their known folkloric uses in this region. However, most of
these species lack botanical, agronomic, phytochemical andvember 2020
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Figure 1. Flow sheet of the valerian fractionation scheme.
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effectiveness as a medicine or as a dietary supplement. There have been
identified 48 valerian species in Argentina (Kutschker, 2011), most of
which grow along the Andes mountain range in Patagonia, while there
are few described for the central region: Cordoba and San Luis (Chiapella
and Demaio, 2015; Zuloaga et al., 1999).
V. carnosa Sm., V. clarionifolia Phil., both known as “~Nancolahuen” (or
“~Namkulawen”, in Mapuzungum language, “White and hawk medicine”,
in English, probably in reference to the elevated areas where the species
grow and where the “~namku” -hawk- can be seen flying) and
V. macrorhiza Poepp. ex DC. are species used by traditional aboriginal
medicine, mainly by the Mapuche ethnicity, in the Patagonia region.
Both “~nancolahuen” species are sold in health food stores and pharmacies
as herbal medicines and their anatomical data have been recently
described (Bach et al., 2014).
The traditional uses for V. effusa Griseb. and V. ferax (Griseb.) H€ock.,
from other regions of the country, has been transferred through genera-
tions by oral and cultural transmission of information up to the present
(Kutschker, 2011). Their subterranean organs are used to treat ailments of
the lungs, stomach, liver, kidneys, waist pain and back pain, and for decay
(Barboza et al., 2009). They are also used as analgesic and sedative to treat
rheumatism (Ochoa et al., 2010), insomnia (Molares and Ladio, 2012),
and for disorders related to heart and bladder (Estomba et al., 2006).
Several compounds have been identified in a variety of species of the
valerian genus. We may mention among them: a complex essential oil (as
the valerenic acid derivatives), several iridoids (named valepotriates and
their decomposition products, the baldrinals; which are labile sesqui-
terpene esters, quite often absent in active extracts), mono- di- and ses-
quiterpenes, lignans (hydroxypinoresinol (Bodesheim and H€olzl, 1997)),
alkaloids, flavonoids, fatty acids, etc (Houghton, 1997, 1999). Neither a
particular compound nor a class of compounds proved to be fully
responsible of the sedative properties (H€olzl, 1997), Furthermore, there
are variable compositions of different valerians with similar activities
(Hobbs, 1989; Houghton, 1999). These results have supported the pre-
sent tentative consensus standing that several different compounds in
valerian extracts act synergistically to produce sedative or tranquillizing
effects (H€olzl, 1997). We have previously identified from the roots and
rhizomes of two valerian species, Valeriana wallichii DC and V. officinalis
L., 6-methylapigenin, a flavone derivative that is a ligand for the
benzodiazepine binding site (BDZ-bs) of the GABAA receptor (the major
neurotransmitter system of the central nervous system –CNS–) with
anxiolytic properties in mice (Wasowski et al., 2002). A glycosylated
flavanone, 2S-hesperidin (Marder et al., 2003) and a glycosylatedflavone,
linarin (Fernandez et al., 2004), with sedative-hypnotic effects were also
identified by us in these species. Relevant synergistic interactions were
found when these two glycosides were assayed in combination with other
components of the same valerian extract (Fernandez et al., 2005;
Fernandez et al., 2004).
In this work, a phytochemical analysis of ethanol extracts of 5
argentine valerian species, V. carnosa Sm., V. clarionifolia Phil., Valeriana
macrorhiza Poepp. ex DC., V. effusa Griseb. and V. ferax (Griseb.) H€ock.
was performed. A research for the presence of ligands of the BDZ-bs of the
GABAA receptor was carried out. Furthermore, the sedative, anxiolytic
and enhancing of thiopental-induced properties were studied.
The studies carried out here may add information about our native
plants, allowing the recognition of their popular use and encouraging the
production on a larger scale. This knowledgemay allow the generation of
new basis to describe quality standards that could be included in new
editions of Pharmacopoeias.
2. Materials and Methods
2.1. Plant material and extraction
The studies were performed on roots and rhizomes of specimens
collected in Patagonia Argentina and in the province of Cordoba,2
Argentina, and authenticated by Dr. Hernan Bach from the “Instituto
Nacional de Tecnología Agropecuaria (INTA)” and the Faculty of
Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires,
Argentina. Vouchers specimens, cited bellowed, have been deposited at
the Herbarium of the Institute of Biological Resources (BAB, BAF),
INTA.
Plant materials were as follows (family Caprifoliaceae):
- V. carnosa Sm.: Río Negro Province, Departamento Capital Cerro Otto:
south hillside; 16-III-2012 H. G. Bach & F. O. Robbiati 578 (BAB,
BAF); 41 090 37S; 71 22045W.
- V. clarionifolia Phil.: Río Negro Province, Departamento: Pilcaniyeu:
2–3 Km North West from the National airport runway; 15-III-2012
2012 H. G. Bach & F. O. Robbiati 561 (BAB, BAF); 41 090 43 S;
71 100 05W.
- V. macrorhiza DC.: Neuquen Province: Departamento: ~Norquin,
Copahue, Mallin: West to the camping; 13-III-2012 H. G. Bach& F. O.
Robbiati 540 (BAB, BAF); 37 490 0,3S; 71 060 25W.
- V. effusa Griseb.: Cordoba Province. Departamento: Colon, Unquillo,
Capilla de Bufo; 26-XI-2010 H. G. Bach 428 (BAB, BAF); 31 110 31S;
64 21047W.
- V. ferax (Griseb.) H€ock.: Cordoba Province. Departamento: Punilla,
Camino de las altas cumbres, the Condor on the side of the provincial
road; 34. 26-XI-2010 H. G. Bach 460 (BAB, BAF); 31 370 9S; 64
43042W.
- V. officinalis L.: grown in Argentina, San Juan Province. Departa-
mento: Calingasta, Barreal, III-2010 M. Ferres s/n (BAB 23452); 31
330 48S; 69 270 56W.
After collection, the fresh roots and rhizomes were washed, dried at
room temperature and protected from light for 30 days, then a part of
them were powdered. The resulting powders were submitted to the
extraction and fractionation scheme shown in Figure 1. Powdered dry
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70 % ethanol and the mixture was kept 2.5 h at 25 C, with stirring. The
filtrate was concentrated to 1/3 of the original volume to eliminate most
of the ethanol and extracted with an equal volume of petroleum ether,
which was discarded. Two-thirds of the aqueous phase obtained was
evaporated to dryness (extract Aqueous 1) and used for pharmacological
evaluations. The other one third was slightly concentrated to eliminate
the remained petroleum ether and was extracted twice with an equal
volume of ethyl ether. Both resulting phases were evaporated to dryness
(extracts Aqueous 2 and Ethylic) and the residues were stored in
absence of light at -20 C. Replicates of the same batch were evaluated.
Aliquots from all the valerian extracts, before dryness, were separated
for phytochemical determinations.2.2. Chemicals and reagents
All chemicals and standard drugs like Folin- Ciocalteu reagent,
aluminium chloride, gallic acid, rutin, apigenin, chlorogenic acid, hes-
peridin, valerenic acid and 2-amino ethyl diphenyl boronic acid ester
(AEDBE) were purchased from Sigma-Aldrich®, Argentina. Sodium
thiopental was obtained from Fada, Biochemie Gesellschaft m.b.H.,
Kundl/Tirol, Austria. Diazepam was from Hoffmann-La Roche. [3H]flu-
nitrazepam (81.8 Ci/mmol) was purchased from PerkinElmer Life and
Analytical Sciences, Boston, MA, USA. Diosmetin was prepared by acid
hydrolysis of diosmin (from Indofine Chemical Company, USA); as pre-
viously described (Marder et al., 2003). 6-Methylapigenin was previously
isolated from Valeriana wallichii DC (Wasowski et al., 2002). All other
reagents and solvents used were of analytical or high-performance liquid
chromatography (HPLC) grade.
2.3. Phytochemical analysis
2.3.1. Determination of total polyphenols content
Total polyphenols were determined by Folin–Ciocalteu method ac-
cording to Makkar and cowokers (Makkar, 2003). Briefly, 50 μL of each
fraction were made up to 0.5 mL with distilled water. 0.25 mL of Folin-
Ciocalteu reagent and 1.25 mL of 20% aqueous sodium carbonate solu-
tion were added. Then the test tubes were vortexed. Absorbance was
measured at 725 nm against blank, after 40 min. The amount of total
polyphenols was expressed as mg galic acid/100 mg dry plant material.
Calibration curve of galic acid was developed. All measurements were
done in triplicate.
2.3.2. Determination of flavonoids
0.1 mL of each extract were added to 1.4 mL of distilled water and
0.50 mL of flavonoids reactive (400 mg of crystalline sodium acetate and
133 mg of crystalline aluminum chloride) dissolved in 100 mL of
extracting solvent (140 mL methanol, 50 mL water, and 10 mL acetic
acid). The absorbance was recorded at 416 nm against blank, after 5 min
at room temperature. Calibration curve of rutin (a natural flavonoid) was
developed. The amount of flavonoids was calculated as mg rutin/100 g
dry plant material.
2.3.3. Determination of hydroxycinnamic acids
0.1 mL of each extract were added to 1.9 mL of absolute ethanol. After
5 min at room temperature, the absorbance was recorded at 328 nm
against blank. Calibration curve of chlorogenic acid was developed. The
amount of hydroxycinnamic acids was calculated as mg chlorogenic
acid/100 g dry plant material.
2.3.4. Thin layer chromatography (TLC) characterization
Extracts were submitted to the characterization by thin layer chro-
matography (TLC). Analyses were conducted in silica gel F254 and cel-
lulose (Merck, Darmstadt, HE, Germany) as stationary phases, employing
glacial acetic acid: water (6:4 v/v) or acetone 100%, and HCl 0.1N,3
respectively. After chromatograms development, the plates were dried,
and the compounds observed under UV light (254 and 365 nm). Then,
plates were sprayed with specific chromogenic reagents according to the
class of compounds investigated (5% AEDBE). The retention factors,
colour and behavior of the spots were compared with chromatographic
profiles of reference substances in the literature (Wagner and Bladt,
1996). Additionally, standard samples of flavonoids were employed for
co-TLC analysis.
2.3.5. High-performance liquid chromatography (HPLC)
Analytical HPLC fractionations were performed using an LKB Phar-
macia apparatus with C-18 reversed phase Vydac columns (5 mm, 0.46
25 cm) (The Separation Group, Hesperia, CA, USA). Each extract was
properly injected into the column and eluted using an aqueous acetoni-
trile (ACN) gradient (v/v) (30 min total analysis time): 10–40% ACN,
0–20 min; 40–80% ACN, 20–30 min. Flow elution was kept constant at 1
mL/min and 200 μL of each sample was injected. The effluent was
monitorized at 280 nm. The lyophilized extracts were resuspended in
water (final concentration: 0.5 mg/mL) and standards were resuspended
in ACN: water (1:1, v/v) (final concentration: 50 μg/mL). All analyses
(Retention times (Rt)) were performed in triplicate. The identification of
compounds was based on comparison of Rt, UV spectrum, and observa-
tion of the increase in the peak area after co-injection of extracts with
standards.
2.4. Animals, administrations and procedures
2.4.1. Animals
Both adult male Swiss mice weighing 25–30 g, used in the pharma-
cological tests, and adult male Wistar rats weighing 200–300 g, used for
binding assays, were obtained from the Central Animal House of the
School of Pharmacy and Biochemistry, University of Buenos Aires. For
behavioral assays mice were accommodated in groups of five in
controlled conditions (20–23 C), free access to food and water, main-
tained on a 12h/12h day/night cycle and light on at 07:00 AM. Housing,
handling, and experimental procedures complied with the recommen-
dations and regulations set forth by the National Institutes of Health
Guide for Care and Use of Laboratory Animals (Guid. Care Use Lab.
Anim., 2011) and the Institutional Committees for the Care and Use of
Laboratory Animals of the Faculty of Pharmacy and Biochemistry, Uni-
versity of Buenos Aires, Argentina (CICUAL, protocol's approved code
numbers: CUDAP: EXP-FYB N: 0058084/2015, N CICUAL FFyB:
02052016-63). Accordingly, all possible efforts were made to minimize
animal suffering and discomfort and to reduce the number of experi-
mental subjects. Hence, the number of animals used was the minimum
number consistent with obtaining significant data. Mice were randomly
assigned to any treatment groups and were used only once. The phar-
macological tests were evaluated by experimenters who were kept un-
aware of the treatment administered and were performed between 10:00
AM and 2:00 PM.
2.4.2. Administrations and procedures
The dried fractions obtained from the Aqueous 1 extracts of each
valerian, were dissolved by the sequential addition of dimethylsulfoxide,
a solution of 0.25% Tween 80 and saline; up to final concentrations of
5%, 20% and 75%, respectively, for the intraperitoneally (i.p.) injections.
For oral gavage (p.o.) administrations the extracts were dissolved in
carboxymethyl cellulose (CMC) 0.5%. Sodium thiopental was dissolved
in saline.
The volume of i.p. injections and p.o. administrations were 0.10–0.20
mL/30 g and 0.30mL/30 g of body weight, respectively. Accordingly, the
assays were performed 30 min and 60 min after i.p. or p.o. administra-
tions, respectively. Food and water were available as necessary, although
mice were fasted two hours before the oral administrations.
In each session, a control group receiving only vehicle (VEH) was
tested in parallel with those animals receiving drug treatment. VEH
C. Marcucci et al. Heliyon 6 (2020) e05691control mice showed no significant differences in any of the tests assayed
compared to mice treated with saline (data not shown). Protein con-
centration was determined by the method of Bradford using bovine
serum albumin as standard (Bradford, 1976). Doses of the extracts used
for this study were chosen based on pilot experiments and previous re-
ports (Fernandez et al., 2004; Marder et al., 2003; Wasowski et al., 2002).
2.5. Pharmacological studies
2.5.2. Behavioral studies
2.5.2.1. Sodium thiopental induced loss of righting reflex assay. The
experiment was conducted using the method described by Joo et al. and
Loscalzo et al. (Joo et al., 1999; Loscalzo et al., 2009). A sub-hypnotic
dose of sodium thiopental (35 mg/kg) was i.p. injected to mice 30 min
after a similar i.p. injection of vehicle or the aqueous 1 extracts of each
valerian (500 mg/kg) (see protocol in Figure 2A). After the sodium
thiopental injection, each mouse was placed in individual cages. When
the mice stood still, they were gently placed on their backs, and the timeFigure 2. Protocol of administration procedures. A) Sodium thiopental induced loss o
and Locomotor activity tests after intraperitoneal (i.p.) and oral administrations (p.o
4
they failed to right themselves was recorded. The latent period (time
between thiopental sodium administration to loss of righting reflex) and
duration of sleep (time between the disappearance and the reappearance
of the righting reflex) was observed for each mouse. It was set a cut off of
1800 s (30 min).
2.5.2.2. Hole board assay. The behavioral profiles of mice under the
influence of the extracts were assessed singly in a walled black Plexiglass
arena with a floor of 60 cm  60 cm and 30 cm high walls, with four
centered and equally spaced holes in the floor, 2 cm in diameter each as
previously described (Fernandez et al., 2006) and illuminated by an in-
direct and dimly light. Each animal was placed in the center of the
apparatus and allowed to explore it for 5 min. The measured parameters
were the number of head dips and the time spent head dipping (recorded
automatically); the number of rearings, groomings and fecal boli de-
positions (counted by the observer). Rearing was taken as the number of
times the mouse was standing on its hind limbs or with its forelimbs
against the wall of the observation cage or in the free air. Grooming is an
innate stereotyped behavior found in most animal species (Spruijt et al.,f righting reflex assay after intraperitoneal (i.p.) injections; B and C) Hole board
.) administrations, respectively.
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picking of the body and pubis with mouth and face washing actions.
The test was performed 30 min after the i.p. injection of 500 mg/kg of
each plant or vehicle, and 1 h after the oral administration of 300 mg/kg
and 600mg/Kg of each plant or vehicle (see protocols in Figure 2B and C,
respectively).
2.5.2.3. Locomotor activity. The spontaneous locomotor activity was
automatically measured as previously described (Fernandez et al., 2006)
and was expressed as total light beam counts per 5 min. Briefly, the
mice were individually placed in a Plexiglass box, with a floor of 30 cm
by 15 cm and 15 cm high walls. On the walls and along the longest axis
the box has 15 infrared movement sensors. Sensor interruptions mea-
sure the animal activity along a single axis (the long one). The inter-
ruption of a sensor and duration of this event were detected and
recorded by a personal computer running a Visual Basic program
developed specifically for this apparatus. This assay was performed, for
each mouse, immediately after the Hole board (35 min after the i.p.
injections, Figure 2B; and 65 min after the oral administration,
Figure 2C). The Hole board apparatus and the Locomotor activity arena
were cleaned with 60 % ethanol between each animal's trial. The ani-
mals were used only once.2.6. Biochemical assays
2.6.1. Tissue preparation
For [3H]-flunitrazepan binding assays, membranes were prepared
according to literature (Medina et al., 1990). Briefly the brains were
rapidly dissected out on ice and the different structures were homoge-
nized in 10 volumes of 0.32 M sucrose and centrifuged at 900 x g for 10
min. The resulting supernatant was centrifuged at 100,000 x g for 30 min
and the pellet washed twice in 25 mM Tris–HCl buffer pH 7.4 at 100,000
x g for 30 min, and stored at -80 C until used.
2.6.2. [3H]-flunitrazepan binding assay
A radioligand binding assay was used to evaluate the putative action
of the plants on the BDZ-bs of the GABAA receptor complex. The binding
of [3H]-flunitrazepam (81.8 Ci/mmol) to the BDZ-bs was performed in
washed crude synaptosomal membranes from rat cerebral cortex pre-
pared as described previously (Medina et al., 1990). The extracts were
added to 0.2–0.3 mg membrane protein suspended in 1 ml of 25 mM
Tris–HCl buffer in the presence of [3H]-flunitrazepam 0.3 nM. In the
screening assays each extract was tested at 1 mg/ml in triplicate. Diaz-
epam (10 μM) was used as positive control. Non-specific binding was
measured in the presence of flunitrazepam 10 μM and represented
5–15% of the total binding. The incubations were carried out at 4 C for 1
h. After incubation, the assays were terminated by filtration under vac-
uum through Whatman GF/A glass-fiber filters followed by washing
three times with 3 ml each of incubation medium. Individual filters were
incubated overnight with scintillation cocktail (OptiPhase ‘HiSafe’ 3)
before measuring radioactivity in a Wallac Rackbeta 1214 liquid scin-
tillation counter.2.7. Statistical analyses
Data for the hole board and the locomotor activity tests were
expressed as mean  SEM (standard error of the mean) and were ana-
lysed by one-way analysis of variance (ANOVA) and post hoc comparisons
between treatments and vehicle were made using Dunnett's multiple
comparison test (Prism 8.00, GraphPad Software). For the sodium thio-
pental induced loss of righting reflex assay, the median (interquartile
range) was calculated and Dunn's multiple comparison test was used after
the Kruskal Wallis test (nonparametric analysis of variance) (Prism 8.00,
GraphPad Software). Significance levels were set at P < 0.05.5
3. Results
3.1. Phytochemical analysis
Results of total phenol, flavonoids, and hydroxycinnamic acids
quantification present in all the Valerian's extracts depicted in Figure 1
are shown in Table 1. All the plant species studied exhibited high content
of phenolic compounds, with values between 125.52 and 890.25 mg
galic acid/100 mg dry plant material, with the following rank: V. effusa
< V. ferax < V. macrorhiza < V. clarionifolia < V. officinalis < V. car-
nosa. Besides, all the plant tested had higher total hydroxycinnamic acids
contents than flavonoids contents, with a similar rank order of V. effusa
< V. macrorhiza < V. clarionifolia < V. ferax < V. officinalis < V.
carnosa.
TLC and HPLC analyses of the aqueous 1 extracts of all valerian
studied in this work showed the existence of hesperidin and of chloro-
genic acid in their composition (Supplementary Materials Figures 1A, 1B
and 1D). However, none of the aqueous 1 extracts showed the presence of
valerenic acid (Supplementary Materials Figure 1C). Additionally, TLC
and HPLC analyses of the ethylic extracts of V. clarionifolia and
V. macrorhiza suggested the presence of diosmetin (Supplementary Ma-
terials Figures 2 and 3) and 6-methylapigenin (Supplementary Materials
Figure 4), respectively. Molecular structures of the compounds are shown
in Supplementary Materials Figure 5.3.2. Pharmacological studies
3.2.1. Effect of argentine valerian species aqueous 1 extracts on sodium
thiopental induced loss of righting reflex assay
The effect of valerian aqueous 1 extracts on sodium thiopental
induced loss of righting reflex assay is shown in Figure 3. By the i.p.
route, at the dose of 500 mg/kg, all the extracts significantly augmented
the time of loss of righting reflex induced by sodium thiopental. The
strength of the extracts action in decreasing order is: V. officinalis >
V. macrorhiza ffi V. carnosa > V. ferax > V. effuse ffi V. clarionifolia
(Figure 3A). Meanwhile, only V. clarionifolia, V. macrorhiza, V. ferax and
V. officinalis were able to significantly reduce the latency time to the
disappearance of the righting reflex of mice (P< 0.05, P< 0.01, P< 0.05
and P < 0.001, respectively) (Figure 3B).
3.2.2. Exploratory behavior of mice after argentine valerian species aqueous
1 extracts administration on the hole board and locomotor activity assays
3.2.2.1. Effects of the extracts by the i.p. route. The behavioral action of
the valerian aqueous 1 extracts on the hole board and locomotor activity
tests by the i.p. route, at the dose of 500 mg/kg, are shown in Figure 4.
Mice administered with V. clarionifolia, significantly increased the
number of holes explored vs. vehicle control group (P < 0.001) in the
hole board assay. However, V. macrorhiza and V. carnosa significantly
decreased the number of holes explored vs. vehicle control group (P <
0.05 and P < 0.01, respectively) in this test. Meanwhile, V. macrorhiza,
V. carnosa and V. feraxwere able to significantly reduce the time the mice
spent head dipping (P < 0.05, P < 0.001 and P < 0.05, respectively)
(Figure 4A). On the other hand, no significant differences were observed
in the number of rearings, number of groomings and number of fecal boli
depositions between mice injected with the extracts vs. vehicle control
group (Figure 4B). Spontaneous locomotor activity of mice was signifi-
cantly reduced by V. carnosa, at a dose of 500 mg/kg, (P < 0.001)
(Figure 4C).
3.2.2.2. Effects of the extracts by the oral route. Those extracts of the
series that showed in vivo activity by the i.p. route in the hole board and
locomotor activity assays, were selected to be tested by the oral route.
Therefore, behavioral actions of the argentine valerians aqueous 1 ex-
tracts of V. carnosa, V. macrorhiza, V. clarionifolia and V. ferax were
Table 1. Total phenolics, flavonoids and hydroxycinnamic acids content of the
argentine valerian species extracts investigated.











V. effusa Aqueous 1 125.52  6.80 8.82  1.42 50.83  4.70
Aqueous 2 88.91  2.04 7.55  0.61 47.17  1.28
Ethylic 25.63  2.31 0.98  0.78 25.74  1.41
V. ferax Aqueous 1 191.56  8.99 32.76  4.87 273.98  15.28
Aqueous 2 133.66  38.49 19.70  1.18 85.21  7.11
Ethylic 123.14  7.55 3.31  1.10 22.81  1.69
V. macrorhiza Aqueous 1 252.85  12.36 14.79  0.55 74.17  6.56
Aqueous 2 145.97  23.15 13.48  1.90 85.44  6.24
Ethylic 87.58  13.60 1.51  0.31 30.83  0.82
V. clarionifolia Aqueous 1 257.36  19.55 22.55  1.19 166.64  14.73
Aqueous 2 178.70  17.99 8.51  1.59 91.96  7.76
Ethylic 20.62  0.50 1.63  0.14 17.20  2.19
V. carnosa Aqueous 1 890.25  156.05 81.98  12.46 1449.54  84.04
Aqueous 2 451.52  27.38 16.95  2.32 1006.81  7.76
Ethylic 75.69  8.47 4.75  3.37 273.93  20.98
V. officinalis Aqueous 1 736.19  34.27 70.03  8.89 676.38  45.19
Aqueous 2 113.82  6.87 11.62  1.99 140.39  17.61
Ethylic 33.74  2.67 2.36  0.10 30.37  1.52
a Mean  2 SD of three independent determinations.
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Figure 5. V. macrorhiza (300 mg/kg) and V. carnosa (600 mg/kg)
significantly increased the number of holes explored vs. vehicle control
group (P < 0.05). Also, V. carnosa was able to increase the time spent
head dipping (P < 0.05) in this test (Figure 5A).
Mice administered with V. macrorhiza (600 mg/kg), V. clarionifolia
(300 mg/kg) and V. ferax (300 mg/kg and 600 mg/kg) significantly
decreased the number of rearings in the hole board assay (P < 0.05, P <
0.01 and P < 0.001, respectively). At the same time, number of groom-
ings of mice were significantly reduced when mice were treated with
V. carnosa and V macrorhiza at the doses of 300 mg kg (P< 0.05) and 600
mg/kg (P < 0.01), and with V. clarionifolia at the dose of 600 mg/kg (P <
0.05) (Figure 5B). On the other hand, the administration of V. macrorhiza
at 600 mg/kg p.o. was able to significantly increase the number of fecal
boli depositions of mice vs. vehicle control group (P < 0.05) (Figure 5B).
Spontaneous locomotor activity of mice was significantly reduced by
V. ferax, at the doses of 300 mg/kg and 600 mg/kg, (P < 0.001). While
V. macrorhiza at the dose of 600 mg/kg p.o. was able to significantly
increase locomotion of mice (Figure 5C).
3.3. Biochemical studies
3.3.1. In vitro [3H]-flunitrazepan binding screening
All the extracts depicted in Figure 1 were evaluated in this assay. The
capacity of these extracts to inhibit the binding of [3H]-FNZ to rat BDZ-bs
of the GABAA receptor is shown in Figure 6. All ethylic extracts were able
to displace the radioligand, at the concentration tested (1 mg/ml),
meanwhile only the aqueous extract 1 of V. effusa and V. clarionifoliawere
able to inhibit the binding of this specific radioligand, at 1 mg/ml. None
of the aqueous extracts 2 were active in this assay.
4. Discussion
The present study evaluated the pharmacological profile of the
ethanol extracts of 5 argentine valerian species, V. carnosa Sm.,
V. clarionifolia Phil., Valeriana macrorhiza Poepp. ex DC., V. effusa Griseb.
and V. ferax (Griseb.) H€ock., including the commercially available
V. officinalis L. Therefore, tests for sedative/anxiolytic-like and6
spontaneous locomotion were conducted in rodents. Moreover, this work
presented an analysis of their phytochemical composition and a study of
the possible presence of ligands for the BDZ-bs of the GABAA receptor,
the major inhibitory system of the CNS.
First, all the plant species were collected in their native region and
techniques for preservation and conservation were performed. According
to the European Pharmacopoeia 2nd edn. (1993), the active principles of
valerian are extracted, using ethanol of suitable concentration, by
maceration or percolation. Similarly, the Dutch Pharmacopoeia 6th edn.,
2nd printing (1966) and the German Pharmacopoeia, “Deutsches Arz-
neibuch”, DAB 10 (1993), indicate the maceration or percolation,
respectively, of one part of valerian root and 5 parts of ethanol (70%, v/
v). According to this information, the extracts studied in this work were
prepared by a 70 % ethanol extraction 10:1 (v/w), 2.5 h with stirring, of
the powdered roots and rhizomes of these 6 valerian species.
We have previously reported the presence of herperidin in the roots
and rhizomes of Valeriana officinalis and V. wallichii and, for the first time,
described its remarkable activity on the CNS (Marder et al., 2003). In
addition, it has been described that the depressant effect of hesperidin
can be partially mediated by an opioid mechanism (Loscalzo et al., 2008)
and through the adenosine receptors (Guzman-Gutierrez and Navarrete,
2009). On the other hand, an apigenin derivative, 6-methylapigenin (40,
5,7-dihydroxy-6-methylflavone), was also reported as a BDZ-bs ligand
from the roots and rhizomes of Valeriana wallichii (Wasowski et al.,
2002). This flavone induced anxiolytic effects in mice treated by the i.p.
route and was able to potentiate hesperidin induce sedation as assessed
by the loss of righting reflex assay (Marder et al., 2003). Several studies
on the Valeriana genus indicate that the main active ingredients are the
valepotriates, lignans, flavonoids, tannins, phenolic acids and essential
oils (Kutschker et al., 2010).
Of all the Patagonian species belonging to this genus, the dry extract
of the whole V. carnosa plant has been the most studied. It has been found
that its valepotriate composition pattern, and especially its valtrates, is
similar to that of V. officinalis. In addition, caffeoyl methyl ester and two
pinoresinol-type lignans have been isolated from their extracts (Molares
and Ladio, 2018) and the presence of chlorogenic and caffeic acid has
been already reported in this species (Guajardo et al., 2018).
All the aqueous 1 extracts studied in this work exhibited high content
of phenolic compounds, had higher total hydroxycinnamic acids contents
than flavonoids contents and have no valerenic acid. In addition, we
demonstrated the presence of hesperidin and of chlorogenic acid in all
the plants assayed and the existence of diosmetin in V. clarionifolia. We
have already reported the CNS action of diosmetin, a flavone derivative,
which evidenced no affinity for the BDZ-bs that demonstrated sedative
properties in mice (Fernandez et al., 2006). Furthermore, the presence of
6-methylapigenin in V. macrorhiza has been acknowledged here.
These native valerian extracts possess several compounds; in conse-
quence their pharmacological activity cannot always be attributed to
only one constituent from the herbal preparation. Hence, the effect of the
extracts could be due to synergistic action of the constituents on different
receptors and other regulatory processes, as we have already described
for V. wallichii and V. officinalis (Fernandez et al., 2005; Fernandez et al.,
2004; Marder et al., 2003).
In the evaluation of the action of a drug on the CNS, it is critical to
study its effect on animal behavior. Similarly, route of administration is
one of the most important factors affecting the results of in vivo effects.
The choice of administration route should depend upon the purpose of
the assay and the nature of the test substance. It is suggested that the i.p.
route is more suitable for primary screening in vivo assays, as it might be
more sensitive than those with oral administration (Hayashi et al., 1989).
Also, the i.p. route (not likely to be used in human) was commonly
selected to determine the inherent toxicity of chemicals. Moreover, it
must be considered that the effects of oral dose are subjected to systemic
bioavailability and hepatic metabolism. Therefore, varied responses
caused by the plant extracts assayed could be attributed to the different
routes of administration that could lead to the production of diverse
(caption on next column)
Figure 3. Effectiveness of argentine valerian species aqueous 1 extracts on so-
dium thiopental induced loss of righting reflex assay in mice. Results are
expressed as mean  S.E.M. of A) time of loss of righting reflex, B) latency time
to lose righting reflex and C) percentage of mice that lost the righting reflex;
after 30 min of an i.p. injection of vehicle (VEH) or the Argentinian valerian
species aqueous 1 extracts (500 mg/kg, i.p.) (see Figure 1). The latency to lose
righting reflex was measured as the time spent between the sodium thiopental
injection (45 mg/kg, i.p.) and the disappearance of the reflex (a cut off of 1800 s
was set for those mice that did not lose the reflex) and the time of loss the
righting reflex was quantified as the time spent between disappearance and
reappearance of righting reflex (cut off of 1800 s) (see Methods). n ¼ number of
mice tested. *P < 0.05, **P < 0.01, ***P < 0.001, significantly different from
vehicle; Dunn's multiple comparison test after Kruskal-Wallis test (nonpara-
metric ANOVA).
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active metabolites. Consequently, the first screening of the in vivo effects
of the native valerian extracts were performed by i.p. administration
procedures. Enhancement of barbital induced sedation is a good index of
CNS depressant activity (Fujimori, 1965). Substances that have CNS
depressant activity either decrease the time for onset of loss of righting
reflex, prolong the duration of this loss or both. Sodium thiopental
induced sedation test revealed that all valerian aqueous 1 extracts (500
mg/kg, i.p.) increased the duration of loss of righting reflex induced by
this barbituric. V. clarionifolia, V. macrorhiza, V. ferax and V. officinalis
extracts were also able to reduce the latency time to the disappearance of
the righting reflex of mice, a parameter that is also measured in this test.
Therefore, all the valerian extracts have CNS depressant activities when
administered by the i.p. route.
The exploratory behavior of mice was studied on the hole board
apparatus. It was reported that a decrease number of the head dips
explored by the animals, as well as in the time spent exploring the holes,
shows CNS depression or sedation (when accompanied by a decrease in
locomotion of rodents) (File and Wardill, 1975). Furthermore, this test
can be also used to study anxiolytic agents (Crawley, 1985) as it com-
bines the assumption that head dipping of animals is inversely propor-
tional to their anxiety-like state in a moderate environment. Therefore,
increased number of head dips on the board means reduced anxiety state
(Bilkei-Gorzo and Gyertyan, 1996). The head dipping behavior of mice in
the hole board test after the i.p. administration of the argentine valerian
aqueous 1 extract (500 mg/kg) showed that V. macrorhiza, V. carnosa and
V. ferax were able to significantly reduce the head dipping behavior of
mice, revealing their depressant properties. Meanwhile, V. clarionifolia
significantly increased the number of holes explored evidencing its
anxiolytic-like effect at this dose by an i.p. injection. On the other hand,
extracts administered by oral gavage evidenced anxiolytic-like effect of
V. macrorhiza (300 mg/kg) and V. carnosa (600 mg/kg), as these extracts
were able to significantly increase head dipping behavior of mice vs.
vehicle control group.
Another important stage in evaluating drug action on CNS is to study
its effect on locomotor activity of the animal. Spontaneous locomotor
activity is a parameter used to measure central excitability of animals,
while its decrease may be closely related to sedation resulting from
depression of the CNS. V. macrorhiza (600 mg/kg, p.o.) was able to
induce an increase in the spontaneous locomotion of mice, whereas
V. carnosa (after its i.p. administration) and V. ferax (after its p.o.
administration) significantly decreased the locomotor activity of mice, as
shown by the results of the locomotor activity test, reinforcing that these
extracts have sedative effects.
Although Valeriana officinalis L. extracts have been used for treating
mild sleep disorders and nervous tension, the pharmacological actions
accounting for its clinical efficacy remain unclear. The effects of different
commercially available preparations of this valerian extract after their
oral administrations were already reported, using different behavioral
paradigms in mice and rats. The data reported that none of the Valeriana
officinalis extracts studied displayed sedative effects (500 or 1000 mg/
kg). Neither spontaneous locomotor activity was reduced, nor was the
Figure 4. Effect of argentine valerian species aqueous 1 extracts in the hole-
board and the locomotor activity tests in mice. Results are expressed as mean 
S.E.M. of A) number of head dips (left scale) and time spent head dipping (s)
(left scale), B) number of rearings (left scale), number of groomings (right scale)
and number of fecal boli (right scale) registered in a 5 min session, 30 min after
the i.p. injections and C) mean  S.E.M. of the spontaneous locomotor activity
counts registered after completing the hole board assay in 5 min sessions and 35
min after the i.p. injections of vehicle (VEH) or 500 mg/kg of the aqueous 1
extract of each valerian. *P < 0.05, **P < 0.01, ***P < 0.001, significantly
different from vehicle; Dunnett's Multiple Comparison test after ANOVA.
Number of animals per group ranged between 6-8, control animals (VEH)
were 31.
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duration of ether-induced narcosis prolonged. In contrast, pronounced
anxiolytic effects were revealed in the plus maze test, a highly well-
known assay to assess anxiety-like in rodents. It was proposed that not
sedative but anxiolytic-like and antidepressant-like activities consider-
ably contribute to the sleep enhancing properties of the valerian extracts
studied in that work (Hattesohl et al., 2008). Accordingly, in the present
study V. officinalis aqueous 1 extract (500 mg/kg, i.p.) could not modify
the behavior of mice in the hole board and locomotor activity assays.
Nevertheless, its sodium thiopental enhancing properties were evi-
denced, as stated above.
Another three parameters are also important to describe CNS effects
of drugs in the hole board test in mice: number of rearing, grooming and
fecal boli. Rearing, also known as vertical locomotion, is characterized by
a vertical posture in which the animal either stands on its hind limbs
while raising up its forearms in the air or placing them on the wall of the
cage (Hattesohl et al., 2008). It is used as a measure of CNS activity
(Aderibigbe and Agboola, 2011) as it is employed by rodents as a survival
strategy; used to adapt and acclimatize to a novel environment for pro-
tection and possible escape route (Blanchard et al., 2001). The ability of
an agent to increase or decrease rearing behavior in rodents has been
linked to increase CNS excitation or depression; consequence of
increased activities of excitatory or inhibitory neurotransmitters,
respectively. Therefore, it is used to classify agents either as CNS stim-
ulant or depressant; both locomotor and rearing activities of rodents are
central excitatory behaviors and indicative of the rodent's explorative
ability. A reduction in rearings in rodents points to a central inhibitory
effect that can be correlated also with reduced anxiety-like behaviors,
when the locomotor activity is not modified. In this study, oral gavage of
V. macrorhiza (600 mg/kg), V. clarionifolia (300 mg/kg) and V. ferax (300
mg/kg and 600 mg/kg) significantly decreased the number of rearings in
the hole board assay.
Grooming is considered a response to stress (D'Aquila et al., 2000;
Moody et al., 1988; Rodríguez Echandía, Broitman and Foscolo, 1983),
novelty induced grooming has long been studied in neurobehavioral
stress research in mice and rats (Enginar et al., 2008; Whyte and
Johnson, 2007). Grooming is a significant factor of the rodent's
behavioral repertoire, it is the initial behavioral response to stressful
situations and is used by animals to lower arousal (Kalueff & Tuohi-
maa, 2004, 2005a, 2005b). Regulation of grooming behavior can be
mediated by multiple brain regions, as well as by various endogenous
agents, and psychotropic drugs. The role of grooming as a behavioral
marker of anxiety has been extensively studied. Additionally, defeca-
tion, quantified by counting the number of fecal boli deposited during
a session, is used as a measure of anxiety as well (Delprato et al., 2017;
Ferre et al., 1995; Hall, 1934). Oral administrations of V. carnosa and V
macrorhiza (300 mg/kg and 600 mg/kg), and V. clarionifolia (600
mg/kg) were able to significantly reduce the number of groomings of
mice. Meanwhile, V. macrorhiza (600 mg/kg), was also able to signif-
icantly increase the number of fecal boli. So, these extracts showed
anxiolytic-like activities.
Neuropharmacology is based simply on the fundamental balance
between chemical excitation and inhibition. These processes are indis-
pensable in the networks of neurons, and most neurons receive inputs
from both excitatory and inhibitory synapses. The GABA system is the
main inhibitory neurotransmitter system in the brain and is the target for
many clinically used drugs to treat anxiety disorders and insomnia. The
results obtained here suggest that the behavioral effects induced by the
plant extracts studied could involve the BDZ-bs of the GABAA, as all the
ethylic extracts (that are a part of aqueous 1 extract) evidenced the
presence of ligands for the BDZ-bs of the GABAA receptor.
In summary:
a) All the valerian extracts showed CNS depressant activities when
administered by the i.p. route as they were able to induce sedation as
Figure 5. Effect of the oral administration of argen-
tine valerian species aqueous 1 extracts in the hole-
board and the locomotor activity tests in mice. Results
are expressed as mean  S.E.M. of A) number of head
dips (left scale) and time spent head dipping (s) (left
scale); B) number of rearings (left scale), number of
groomings (right scale) and number of fecal boli (right
scale) registered in a 5 min session, 60 min after the
oral administrations and C) mean  S.E.M. of the
spontaneous locomotor activity counts; registered
after completing the hole board assay in 5 min ses-
sions and 65 min after the oral administration of
vehicle (VEH), 300 mg/kg or 600 mg/kg of the
aqueous 1 extract of each valerian. *P < 0.05, **P <
0.01, ***P < 0.001, significantly different from
vehicle; Dunnett's Multiple Comparison test after
ANOVA. Number of animals per group ranged be-
tween 6-10, control animals (VEH) were 23.
C. Marcucci et al. Heliyon 6 (2020) e05691assessed by the sodium thiopental loss-of-righting reflex assay.
Furthermore, all the extracts evidenced the presence of ligands for the
BDZ-bs of the GABAA receptor.
b) V. clarionifolia extract evidenced anxiolytic-like effects in mice as it
stimulated exploratory activity, by increasing the number of holes9
explored in the hole board test after its i.p. administration and by
reducing the number of rearings and grooming behaviors measured in
this assay, with no altered locomotion, by the oral route.
c) V. ferax extract induced sedative effects in mice in the hole board
assay, as this extract was able to decrease the exploratory behavior of
Figure 6. Capacity of the argentine valerian species extracts to inhibit the
binding of [3H]-flunitrazepam to the BDZ-bs of the GABAA receptor. Results are
expressed as mean  S.E.M. of percentage of binding inhibition of valerian
aqueous 1, aqueous 2 and ethylic extracts (1.0 mg/kg) (see Figure 1). Inhibition
<30% was considered as no inhibition. Diazepam (10 μM) showed 90 % of
binding inhibition.
C. Marcucci et al. Heliyon 6 (2020) e05691mice (reduced time mice spent head dipping, i.p., and decreased
rearings, p.o.).
d) V. macrorhiza extract showed anxiolytic-like activities after oral ad-
ministrations, as this plant produced an increase in the hole param-
eters and in the number of defecations as well as a decrease in the
number of rearings and grooming behaviors measured in the hole
board assay. Moreover, spontaneous locomotion of mice was
augmented after its oral administrations. Otherwise, V. macrorhiza
extract showed a decrease in exploratory behaviors after its i.p. in-
jection, as the hole parameters of mice measured in the hole board
assay were decreased, evidencing its depressant CNS activity.
e) V. carnosa extract showed anxiolytic-like activities after oral admin-
istrations, as this extract induced an increase in the number of holes
explored and a decrease in the number of groomings measured in the
hole board assay. Also, mice evidenced no motor impairment after its
oral administrations. Furthermore, it showed a decrease in locomo-
tion and exploratory behaviors after its i.p. injection, as the hole
parameters of mice measured in the hole board assay were decreased,
evidencing its depressant CNS activity.
5. Conclusion
Physiopathology of stress, anxiety and sleep disorders involves
numerous pathways, and different neurotransmitters participate on its
underlying mechanisms. This work does not provide evidence to deter-
mine the exact mechanisms responsible for the observed effects, and
therefore, further studies will be needed. However, the results bring to
light the potential use of these valerian extracts as an alternative natural
source for the treatment of CNS disorders to offer a better quality of life to
patients affected by anxiety, stress, and insomnia.
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